A61K 9/1688
Resulting in pure drug agglomerate optionally containing up to 5% of excipient
Official title: {resulting in pure drug agglomerate optionally containing up to 5% of excipient}
A61K9/1688 (Resulting in pure drug agglomerate optionally containing up to 5% of excipient) appears on 520 US grants and 718 published applications in this corpus.
Search patents in A61K- Granted patents
- 520
- Published applications
- 718
- Assignees
- 396
- Inventors
- 1,523
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 6 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 3 | 0 |
| 1994 | 7 | 0 |
| 1995 | 1 | 0 |
| 1996 | 8 | 0 |
| 1997 | 5 | 0 |
| 1998 | 9 | 0 |
| 1999 | 10 | 0 |
| 2000 | 12 | 0 |
| 2001 | 13 | 4 |
| 2002 | 14 | 28 |
| 2003 | 26 | 48 |
| 2004 | 9 | 47 |
| 2005 | 20 | 56 |
| 2006 | 13 | 25 |
| 2007 | 11 | 27 |
| 2008 | 9 | 16 |
| 2009 | 8 | 25 |
| 2010 | 14 | 57 |
| 2011 | 7 | 33 |
| 2012 | 15 | 26 |
| 2013 | 33 | 12 |
| 2014 | 24 | 21 |
| 2015 | 22 | 19 |
| 2016 | 18 | 31 |
| 2017 | 17 | 25 |
| 2018 | 22 | 28 |
| 2019 | 18 | 26 |
| 2020 | 25 | 20 |
| 2021 | 19 | 38 |
| 2022 | 26 | 34 |
| 2023 | 14 | 27 |
| 2024 | 12 | 24 |
| 2025 | 13 | 12 |
| 2026 | 5 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cannabidiol nanodrug formulations and methods for use of the same6 Oct 2026US 12,751,959 B2University of Miami
- Plant essential oil amino acid composition and preparation method therefor1 Sep 2026US 12,721,821 B2Cocrystal Technology (Jiaxing) Co., Ltd.
- Methods, systems, and materials for making unit dosage forms10 Mar 2026US 12,569,404 B2OFD BioPharma, LLC
- Biodegradable implant including naltrexone10 Mar 2026US 12,569,430 B2
- Process for preparing high-density quercetin6 Jan 2026US 12,516,034 B2Tradichem Industrial Services, S.L.
- Method of drying a therapeutic product24 Sep 2026US 2026/0283960 A1Spraying Systems Co.
- Process for preparation of dual gip/glp-1 peptides having controlled particle size10 Sep 2026US 2026/0265332 A1Assia Chemical Industries Ltd.
- Biodegradable Implant Including Naltrexone27 Aug 2026US 2026/0248716 A1Biocorrx
- Composition for preventing and/or treating metabolic disorders and method of its preparation23 Jul 2026US 2026/0207656 A1Pharmako Biotechnologies PTY Limited
- Method for industrial production of spray-dried piperacillin-tazobactam powder9 Jul 2026US 2026/0191784 A1Nanjing Pharmacare Co., Ltd.
Most cited
By later US patents
- Porous drug matrices and methods of manufacture thereof357US 6,395,300 B1Acusphere, Inc. · 2002
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- Method of grinding pharmaceutical substances284US 5,518,187 ANano Systems L.L.C. · 1996
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Porous drug matrices and methods of manufacture thereof269US 6,932,983 B1Acusphere, Inc. · 2005